Product Images Gabapentin

Gabapentin Tablets, USP are available in a pack of 100 Tablets (10 x 10). It is a prescription-only medicine. The medication needs to be stored at a temperature of 20° to 25°C (88" to 77°F) and should be kept out of reach of children. Patients should not use it if the blister is broken. The drug product in the package belongs to NDC # 68382-204, Zydus Pharmaceuticals (USA) Inc. The tablets should be dispensed along with the medication guide. American Health Packaging distributes this drug, and it has the NDC 60687-507-01.*

Gabapentin is a medication available in tablet form with a dosage strength of 800 mg. The output contains various incomplete and misrecognized texts, but it is clear that it pertains to Gabapentin medication in tablet form.*

NDC 60687-518-01 is a Gabapentin drug tablet provided in containers of 100 tablets (10 x 10) that are only available under prescription (Rx only). Each coated tablet contains Gabapentin, USP. 800mg, with usual dosages explained in detail in the package insert. The tablets have to be stored between 20°C to 25°C (68" to 77°F) with temporary excursions between 15° to 30°C (39" o B6°F). The drug has to be kept safe and unreachable from children. The manufacturer of the drug is Zydus Pharmaceuticals (USA) Inc., which is distributed by American Health Packaging. This text seems to detail the usage instructions and necessary warnings for this particular drug.*

The text appears to represent a graph or table showing the Mean Pain Score, a 4-Week Dose Titration Period, and a 4-Week Fixed Dose Period with Placebo and Gabapentin at 3600mg/day. The baseline and week 1 data points are also shown on the graph. It is difficult to provide a useful description without additional context or a visual of the graph.*

The text appears to be describing a clinical trial for pain management with a medication called Gabapentin. The trial has two phases: a 3-week dose titration period and a 4-week fixed dose period. The participants are divided into three groups: placebo, Gabapentin 1800mg/day, and Gabapentin 2400mg/day. The graph displays the mean pain score over the 7-week period (baseline, weeks 1-7) for the three groups.*

This text appears to be a graph or chart showing percentage values on the y-axis, with a range from 0% to 100%, and some values and a symbol (*) at various points on the x-axis. Additionally, there is some text indicating "Study 2" and some financial values in GBP. The meaning and context of this information is not clear without further information.*